Literature DB >> 8590321

Upregulation of NF-kappa B-dependent gene expression mediated by the p75 tumor necrosis factor receptor.

P Rao1, K C Hsu, M V Chao.   

Abstract

Tumor necrosis factor (TNF-alpha) interacts with two transmembrane receptor proteins, p55TNFR and p75TNFR, which are members of a family of cell surface molecules that include the Fas antigen, CD27, CD30, CD40, OX40, a Shope fibroma viral protein, and the low-affinity p75 neurotrophin receptor. Although the p55 TNF receptor has been shown to be primarily responsible for the biologic responses of TNF-alpha, the exact involvement of the p75 TNF receptor in signaling events is unclear. Here we show that expression of a human cDNA clone for p75 in COS-1 and 3T3 cells results in the constitutive activation of an TNF-inducible NF-kappa B-containing promoter. Analysis of a number of chimeric p75 receptor cDNA constructs further suggests that this activity requires the cytoplasmic domain of the p75 receptor. These results therefore indicate that the p75 TNF receptor is capable of mediating signal transduction.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8590321     DOI: 10.1089/jir.1995.15.171

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  13 in total

1.  Sulfoglucuronosyl paragloboside promotes endothelial cell apoptosis in inflammation: elucidation of a novel glycosphingolipid-signaling pathway.

Authors:  Somsankar Dasgupta; Guanghu Wang; Robert K Yu
Journal:  J Neurochem       Date:  2011-10-11       Impact factor: 5.372

2.  IFNgamma enhances microglial reactions to hippocampal axonal degeneration.

Authors:  M B Jensen; I V Hegelund; N D Lomholt; B Finsen; T Owens
Journal:  J Neurosci       Date:  2000-05-15       Impact factor: 6.167

3.  Tumor necrosis factor alpha (TNF-alpha) receptor-II is required for TNF-alpha-induced leukocyte-endothelial interaction in vivo.

Authors:  Unni M Chandrasekharan; Maria Siemionow; Murat Unsal; Lin Yang; Earl Poptic; Justin Bohn; Kagan Ozer; Zhongmin Zhou; Philip H Howe; Marc Penn; Paul E DiCorleto
Journal:  Blood       Date:  2006-10-26       Impact factor: 22.113

Review 4.  The function of tumour necrosis factor and receptors in models of multi-organ inflammation, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease.

Authors:  G Kollias; E Douni; G Kassiotis; D Kontoyiannis
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

Review 5.  Ethanol and Cytokines in the Central Nervous System.

Authors:  Marisa Roberto; Reesha R Patel; Michal Bajo
Journal:  Handb Exp Pharmacol       Date:  2018

6.  Divergent roles for p55 and p75 TNF-alpha receptors in the induction of plasminogen activator inhibitor-1.

Authors:  Manjula Pandey; Gurol Tuncman; Gökhan S Hotamisligil; Fahumiya Samad
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

Review 7.  Regulation of serum amyloid A protein expression during the acute-phase response.

Authors:  L E Jensen; A S Whitehead
Journal:  Biochem J       Date:  1998-09-15       Impact factor: 3.857

8.  Differential expression, shedding, cytokine regulation and function of TNFR1 and TNFR2 in human fetal astrocytes.

Authors:  Sun Ju Choi; Kyoung-Ho Lee; Hyun Sook Park; Soo-Ki Kim; Choon-Myung Koh; Joo Young Park
Journal:  Yonsei Med J       Date:  2005-12-31       Impact factor: 2.759

9.  Release of nonmuscle myosin II from the cytosolic domain of tumor necrosis factor receptor 2 is required for target gene expression.

Authors:  Unni M Chandrasekharan; Lisa Dechert; Uchechukwu I Davidson; Matthew Waitkus; Lori Mavrakis; Katherine Lyons; Jordan R Beach; Xiaoxia Li; Thomas T Egelhoff; Paul L Fox; Paul E DiCorleto
Journal:  Sci Signal       Date:  2013-07-16       Impact factor: 8.192

10.  A critical role of the p75 tumor necrosis factor receptor (p75TNF-R) in organ inflammation independent of TNF, lymphotoxin alpha, or the p55TNF-R.

Authors:  E Douni; G Kollias
Journal:  J Exp Med       Date:  1998-10-05       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.